| 1 |
Beck J, Oellerich M, Schulz U, et al. Donor-derived cell-free DNA is a novel universal biomarker for allograft rejection in solid organ transplantation[J]. Transplant Proc, 2015，47(8): 2400-2403.
|
| 2 |
Smith JM, Weaver T, Skeans MA, et al. OPTN/SRTR 2018 Annual Data Report: Intestine[J]. Am J Transplant, 2020，20 Suppl s1: 300-339.
|
| 3 |
Valapour M, Lehr CJ, Skeans MA, et al. OPTN/SRTR 2018 Annual Data Report: Lung[J]. Am J Transplant, 2020，20 Suppl s1: 427-508.
|
| 4 |
Kwong A, Kim WR, Lake JR, et al. OPTN/SRTR 2018 Annual Data Report: Liver[J]. Am J Transplant, 2020，20 Suppl s1: 193-299.
|
| 5 |
Hart A, Smith JM, Skeans MA, et al. OPTN/SRTR 2018 Annual Data Report: Kidney[J]. Am J Transplant, 2020，20 Suppl s1: 20-130.
|
| 6 |
Colvin M, Smith JM, Hadley N, et al. OPTN/SRTR 2018 Annual Data Report: Heart[J]. Am J Transplant, 2020，20 Suppl s1: 340-426.
|
| 7 |
Kandaswamy R, Stock PG, Gustafson SK, et al. OPTN/SRTR 2018 Annual Data Report: Pancreas[J]. Am J Transplant, 2020，20 Suppl s1: 131-192.
|
| 8 |
Whitlam JB, Ling Ling, Skene A, et al. Diagnostic application of kidney allograft-derived absolute cell-free DNA levels during transplant dysfunction[J]. Am J Transplant, 2019，19(4): 1037-1049.
|
| 9 |
Zheng YW, Chan KC, Sun H, et al. Nonhematopoietically derived DNA is shorter than hematopoietically derived DNA in plasma: a transplantation model[J]. Clin Chem, 2012，58(3): 549-558.
|
| 10 |
Lui YY, Chik KW, Chiu RW, et al. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation[J]. Clin Chem, 2002，48(3): 421-427.
|
| 11 |
Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients[J]. Nat Rev Cancer, 2011，11(6): 426-437.
|
| 12 |
Celec P, Vlková B, Lauková，et al. Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseases[J]. Expert Rev Mol Med, 2018，20: e1.
|
| 13 |
Yu SC, Lee SW, Jiang P, et al. High-resolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing[J]. Clin Chem, 2013，59 (8): 1228-1237.
|
| 14 |
Shen J, Zhou Y, Chen Y, et al. Dynamics of early post-operative plasma ddcfDNA levels in kidney transplantation: a single-center pilot study[J]. Transpl Int, 2019，32(2): 184-192.
|
| 15 |
Sigdel TK, Vitalone MJ, Tran TQ, et al. A rapid noninvasive assay for the detection of renal transplant injury[J]. Transplantation, 2013，96(1): 97-101.
|
| 16 |
Beck J, Bierau S, Balzer S, et al. Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury[J]. Clin Chem, 2013，59(12): 1732-1741.
|
| 17 |
Gielis EM, Beirnaert C, Dendooven A, et al. Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay[J]. PLoS One, 2018，13(12): e0208207.
|
| 18 |
De Vlaminck I, Martin L, Kertesz M, et al. Noninvasive monitoring of infection and rejection after lung transplantation[J]. Proc Natl Acad Sci U S A, 2015，112(43): 13336-13341.
|
| 19 |
Schütz E, Blum A, Beck J, et al. Graft-derived cell-free DNA - a promising rejection marker in liver transplantation - results from a prospective multicenter trial[J]. Clin Chem, 2016，62(10): S34.
|
| 20 |
Bloom RD, Bromberg JS, Poggio ED, et al. Cell-free DNA and active rejection in kidney allografts[J]. J Am Soc Nephrol, 2017，28(7): 2221-2232.
|
| 21 |
Sigdel TK, Archila FA, Constantin T，et al. Optimizing detection of kidney transplant injury by assessment of donor-derived cell-free DNA via massively multiplex PCR[J]. J Clin Med, 2018，8(1): 19.
|
| 22 |
Huang E, Sethi S, Peng A, et al. Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients[J]. Am J Transplant, 2019，19(6): 1663-1670.
|
| 23 |
Macher HC, Suárez-Artacho G, Guerrero JM, et al. Monitoring of transplanted liver health by quantification of organ-specific genomic marker in circulating DNA from receptor[J]. PLoS One, 2014, 9: e113987.
|
| 24 |
Schütz E, Fischer A, Beck J, et al. Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: a prospective, observational, multicenter cohort study[J]. PLoS Med, 2017，14(4): e1002286.
|
| 25 |
von Meijenfeldt FA, Burlage LC, Bos S, et al. Elevated plasma levels of cell-free DNA during liver transplantation are associated with activation of coagulation[J]. Liver Transplant, 2018，24(12): 1716-1725.
|
| 26 |
Duque-Afonso J, Waterhouse M, Pfeifer D, et al. Cell-free DNA characteristics and chimerism analysis in patients after allogeneic cell transplantation[J]. Clin Biochem, 2018，52: 137-141.
|
| 27 |
Prakash K, Aggarwal S, Bhardwaj S, et al. Serial perioperative cell-free DNA levels in donors and recipients undergoing living donor liver transplantation[J]. Acta Anaesthesiol Scand, 2017，61(9): 1084-1094.
|
| 28 |
Snyder TM, Khush KK, Valantine HA, et al. Universal noninvasive detection of solid organ transplant rejection[J]. Proc Natl Acad Sci U S A, 2011，108(15): 6229-6234.
|
| 29 |
De Vlaminck I, Valantine HA, Snyder TM, et al. Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection[J]. Sci Transl Med, 2014，6(241): 241ra77.
|
| 30 |
Agbor-Enoh S, Tunc I, De Vlaminck I, et al. Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method of detection of acute rejection and graft injury after heart transplantation[J]. J Heart Lung Transplant, 2017，36(9): 1004-1012.
|
| 31 |
Tanaka S, Sugimoto S, Kurosaki T, et al. Donor-derived cell-free DNA is associated with acute rejection and decreased oxygenation in primary graft dysfunction after living donorlobar lung transplantation[J]. Sci Rep, 2018，8(1): 15366.
|
| 32 |
Gala-Lopez BL, Neiman D, Kin T, et al. Beta cell death by cell-free DNA and outcome after clinical islet transplantation[J]. Transplantation, 2018，102(6): 978-985.
|
| 33 |
García Moreira V, Prieto García B, Baltar Martin JM, et al. Cell-free DNA as a noninvasive acute rejection marker in renal transplantation[J]. Clin Chem, 2009，55(11): 1958-1966.
|
| 34 |
Oellerich M, Shipkova M, Asendorf T, et al. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: results from a prospective observational study[J]. Am J Transplant, 2019，19(11): 3087-3099.
|
| 35 |
Oellerich M, Schutz E, Kanzow P, et al. Use of graft-derived cellfree DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation[J]. Ther Drug Monit, 2014，36(2): 136-140.
|
| 36 |
Londoño MC, Danger R, Giral M, et al. A need for biomarkers of operational tolerance in liver and kidney transplantation[J]. Am J Transplant, 2012，12(6): 1370-1377.
|
| 37 |
Gielis EM, Ledeganck KJ, De Winter BY, et al. Cell-free DNA: an upcoming biomarker in transplantation[J]. Am J Transplant, 2015，15(10): 2541-2551.
|